Concepedia

Paul A. Elzinga

PA

8

Publications

589

Citations

8

H-Index

1987

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Purdue University West Lafayette

Paul A. Elzinga is an author at Bristol-Myers Squibb (United States) specializing in medicine, engineering, and drug discovery.

Top concepts

MedicineEngineeringBiophysicsBiochemistryPharmacologySpectroscopyDrug DiscoveryNatural SciencesLaser SpectroscopyOptical Characterization

Publications per year

1987–2020

8

Publications

8

Pump/probe method for fast analysis of visible spectral signatures utilizing asynchronous optical sampling

Paul A. Elzinga, Ronald J. Kneisler, Fred E. Lytle et al. · Applied Optics · 1987 · 186 citations

Visible Spectral Signatures, Engineering, Spectrum Estimation +17

Pump/Probe Spectroscopy by Asynchronous Optical Sampling

Paul A. Elzinga, Fred E. Lytle, Yanan Jian et al. · Applied Spectroscopy · 1987 · 112 citations

Engineering, Laser Science, Laser Applications +18

Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK)

Scott H. Watterson, Qingjie Liu, Myra Beaudoin Bertrand et al. · Journal of Medicinal Chemistry · 2019 · 104 citations · Full text

Tyrosine Kinase, Immunology, Quantitative Pharmacology +20

Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2

Chunjian Liu, James C. Lin, Charles M. Langevine et al. · Journal of Medicinal Chemistry · 2020 · 76 citations · Full text

Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors

Chunjian Liu, James C. Lin, Ryan Moslin et al. · ACS Medicinal Chemistry Letters · 2019 · 49 citations · Full text

Rows per page

1–5 of 8